Send by pharmatutor19

Candidate should be MBA with Pharmacy/MBA with Medical degree with MD/PhD in Pharmacology with 3-5 yrs Pharma work experience preferably as a business analyst within pharma industry and/or in medico-marketing area with strong commercial interface. [...]

Send by Pharmaceutical Business Review

Novartis is planning to seek regulatory approval for its tablet with embedded microchip over the next one and half years, as part of its plans to bring the [...]

Send by pharmatutor19

Performs pharmacovigilance activities for all assigned Novartis projects or products including identifying and analyzing safety signals based on a comprehensive evaluation of postmarketing data and Serious Adverse Events (SAEs) from clinical trials. [...]

Send by MarketWatch

Novartis closed the sale of 52% of Alcon in August and then consolidated the unit in its reports. “Approvals such as Gilenya, a breakthrough first-line oral [...]

Send by BusinessWeek

Swiss pharmaceutical company Novartis AG says it is cutting 1400 sales jobs at its US subsidiary. The company says the cuts at New Jersey-based Novartis [...]

Send by Zacks.com

Novartis' (NVS - Snapshot Report) third quarter 2010 earnings per ADR (excluding special items) of $1.36 handsomely beat the Zacks Consensus Estimate by [...]

Send by FiercePharma

Just a week after denying that "Roche-style" job cuts were in the offing at Novartis ($NVS), the company now says it will slice about 1400 positions from [...]

Send by pharmatutor19

Candidate should be MBA with Graduate/Post Graduate in Pharmacy/Science with 2 years+ experience in Business Analytics (Pharma) with at least 1 year in Market Research with specific experience of producing Key Performance Indicators or similar monthly reports for Senior Management. [...]

Send by lilharut

Novartis has been publicizing their new pancreatic cancer drug, Afinitor, stating that this medication has been shown to give people who suffer with advanced pancreatic cancer, two times more living time than those who do not take this medication. The pancreatic cancer drug is said to decrease cancerous tumor growth. [...]

Send by pharmatutor19

MBA with Graduate/Post Graduate in Pharmacy/Science with 2+ years experience in Sales Force Effectiveness/Analytics (Pharma) with specific experience of producing Key Performance Indicators or similar monthly reports for Senior Management. [...]

Send by Equity Bulls

Novartis India Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2010. The Net Sales / Income from operations was at [...]

Send by MarketWatch

Net profit at Novartis (NYSE:NVS) (SWX:CH:NOVN) increased to $2.32 billion, or 99 cents a share, from $2.11 billion, or 93 cents, in the year-earlier period [...]

Send by The Associated Press

GENEVA (AP) — Swiss pharmaceutical company Novartis AG says it has halted late-stage development of a new drug for lung cancer and will write off $120 [...]

Send by Siliconrepublic.com

such as Nokia, Panasonic, Sony, Hewlett-Packard (HP) and Vodafone, as well as pharmaceutical companies such as Pfizer, Novartis and GlaxoSmithKline. [...]

Send by Moneycontrol.com

Novartis India has declared its second quarter results. The company's Q2 net profit was up at Rs 40.6 crore versus Rs 33.3 crore, year-on-year, YoY. [...]

Send by swissinfo.ch

Pharmaceutical company Novartis paid $422 million (SFr420 million) in September, the same month that engineering concern ABB handed over $58.3 million. [...]

Send by Daijiworld.com

Mangalore, Oct 22: The Mangalore Coastal Round Table 190 (MCRT 190) in association with Novartis India Ltd. held a Free Bone Density Camp for Osteoporosis [...]

Send by francola

On Thursday, May 20th, Novartis AG was hit with the largest employment discrimination verdict on record (Velez v. Novartis Corp.). The federal jury awarded $250 million in punitive damages to the 5,600 plaintiffs involved in the class action suit. [...]

Send by WooEB

Basel, Switzerland-based Novartis AG reported a net income of $2.28 billion in the third quarter, up from $2.1 billion a year earlier, showing an increase [...]

Send by Legal News Line

It is the second time the court has consolidated two of King's suits, the first time involving Novartis and GlaxoSmithKline. Par and Mylan claimed that a [...]

Send by The Associated Press

PHILADELPHIA — Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying [...]

6, 2010 Novartis Raised To Overweight From Equalweight By Morgan Stanley May 7, 2010 FDA Accepts Novartis Vaccines' sBLA to Expand Indication of [...]

Novartis Oncology is passionate about discovering new cancer drugs, opening new doors for cancer treatment and finding innovative solutions for cancer [...]

In 2000, Novartis was one of the first signatories of the United Nations Global Compact. The Leaders Summit 2010, marking the 10th anniversary of the [...]

We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. [...]